Literature DB >> 7859047

Particle size: the key to the atherogenic lipoprotein?

I Rajman1, S Maxwell, R Cramb, M Kendall.   

Abstract

Using different analytical methods, up to 12 low-density lipoprotein (LDL) subfractions can be separated. LDL particle size decreases with increasing density. Smaller, denser LDL particles seem more atherogenic than the larger, lighter particles, based on the experimental findings that smaller LDL particles are more susceptible for oxidation in vitro, have lower binding affinity for the LDL receptors and lower catabolic rate, have a higher concentration of polyunsaturated fatty acids, and potentially interact more easily with proteoglycans of the arterial wall. Clinical studies have shown that a smaller LDL subfraction profile is associated with an increased risk of heart disease, even when total cholesterol level is only slightly raised. There is a strong inverse association between LDL particle size and triglyceride concentrations. Although LDL particle size is genetically determined, its phenotypic expression may also be affected by environmental factors such as drugs, diet, obesity, exercise or disease. Factors that shift the LDL subfractions profile towards larger particles may reduce the risk of heart disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7859047     DOI: 10.1093/oxfordjournals.qjmed.a068888

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  5 in total

Review 1.  LDL particle size: an important drug target?

Authors:  I Rajman; P I Eacho; P J Chowienczyk; J M Ritter
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

Review 2.  The physiology of lipoproteins.

Authors:  Thomas N Tulenko; Anne E Sumner
Journal:  J Nucl Cardiol       Date:  2002 Nov-Dec       Impact factor: 5.952

3.  A Simple Economical Method for Assay of Atherogenic Small Dense Low-Density Lipoprotein-Cholesterol (sdLDL-C).

Authors:  R S Renjith; N Jayakumari
Journal:  Indian J Clin Biochem       Date:  2011-02-05

Review 4.  Endothelial dysfunction in human diabetes.

Authors:  Sari Mäkimattila; Hannele Yki-Järvinen
Journal:  Curr Diab Rep       Date:  2002-02       Impact factor: 4.810

5.  Observational study of lipid profile and LDL particle size in patients with metabolic syndrome.

Authors:  Natalia Sancho-Rodríguez; Francisco V Avilés-Plaza; Esteban Granero-Fernández; Antonio M Hernández-Martínez; María Dolores Albaladejo-Otón; Pedro Martínez-Mernández; Soledad Parra-Pallarés
Journal:  Lipids Health Dis       Date:  2011-09-21       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.